Patent 7259245 was granted and assigned to Genentech on August, 2007 by the United States Patent and Trademark Office.
The present invention relates to nucleotide sequences, including expressed sequence tags (ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing, immunoadhesins, agonists and antagonists (including antibodies) to human & vertebrate fused.